Hostname: page-component-8448b6f56d-sxzjt Total loading time: 0 Render date: 2024-04-25T01:48:20.106Z Has data issue: false hasContentIssue false

Antidepressant-induced hyponatremia

Published online by Cambridge University Press:  23 March 2020

S. Gómez Sánchez
Affiliation:
Hospital Clínico Universitario de Valladolid, Psychiatry, Valladolid, Spain
A. Rodríguez Campos
Affiliation:
Hospital Clínico Universitario de Valladolid, Psychiatry, Valladolid, Spain
R. Hernández Antón
Affiliation:
Hospital Clínico Universitario de Valladolid, Psychiatry, Valladolid, Spain
L. Gallardo Borge
Affiliation:
Hospital Clínico Universitario de Valladolid, Psychiatry, Valladolid, Spain
A. Álvarez Astorga
Affiliation:
Hospital Clínico Universitario de Valladolid, Psychiatry, Valladolid, Spain

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Hyponatremia is one of the electrolytic disorders most comonly observed among general hospitalized populations (2% of hospitalized patients). A form of hyponatremia is the syndrome of inappropriate antidiuretic hormone secrection (SIADH). One of its diverse causes is medication. Selective serotonine reuptake inhibitors (ISRSs) can cause hyponatremia due to SIADH, particularly among elderly population.

Clinical case report

A 81-year-old female treated with paroxetine 20 mg/day because of depression. Two weeks later she starts feeling nausea, somnolence and motor inhibition. The sodium level previous to the onset of treatment was normal but after two weeks it has decreased to 121 mEq/L, pointing to SIADH induced by ISRSs.

Discussion

The incidence of hyponatremia among elderly patients treated with antidepressants of ISRSs class has increased. The prevalence varies between 0.5 and 25%. Although half of the patients are asymptomatic, the mortality is rate may reach 25%. It generally develops during the first month of treatment and is reversible between 2 and 28 days after the suspension of the ISRSs.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EW191
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.